Mostrando 10 resultados de: 10
Filtros aplicados
Publisher
Current Pharmaceutical Design(3)
Advances in Pharmacological Sciences(1)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Cardiology Research and Practice(1)
Current Psychiatry Research and Reviews(1)
Área temáticas
Enfermedades(8)
Fisiología humana(3)
Medicina y salud(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Psicología aplicada(1)
Origen
scopus(10)
Chronobiology and chronotherapy in depression: Current knowledge and chronotherapeutic promises
ArticleAbstract: Background: Depression is a heavily prevalent mental disorder. Symptoms of depression extend beyondPalabras claves:Agomelatine, Chronobiology, Chronodisruption, Chronotherapy, Depression, SleepAutores:Batista M.J., Cano-Ponce C., Chávez-Castillo M., Díaz E.A., González M.C., Ortega A., Pírela D., Riaño M., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusC-reactive protein: Clinical and epidemiological perspectives
ReviewAbstract: An important etiopathogenic component of cardiovascular disease is atherosclerosis, with inflammatioPalabras claves:Autores:Añez-Ramos R., Apruzzese V., Chávez-Castillo M., Martínez M.S., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore BermúdezFuentes:scopusDepression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
ReviewAbstract: Depression is currently recognized as a crucial problem in everyday clinical practice, in light of ePalabras claves:Autores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusMetabolic syndrome: Is it time to add the central nervous system?
ReviewAbstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hypPalabras claves:Alzheimer’s disease, Diabetes mellitus type 2, Insulin Resistance, Metabolic syndrome, Mild cognitive impair-mentAutores:Añez-Ramos R., Chávez-Castillo M., Dávila L.C.A., Díaz-Camargo E.A., Durán-Agüero S., González M.C., Gravini-Donado M., Nava M., Parra H., Pírela D., Rina Ortiz, Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusPhytotherapy for cardiovascular disease: A bench-to-bedside approach
ReviewAbstract: At present, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality world-Palabras claves:atherosclerosis, Cardiovascular disease, dyslipidemia, Hypertension, Medicinal herbs, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Ortega A., Pírela D., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusSearching for the ideal hypnotic: Pharmacological treatment of Insomnia
ArticleAbstract: Insomnia is a sleep disorder characterized by difficulty for the onset or maintenance of sleep, as wPalabras claves:benzodiazepines, Ideal hypnotic, Insomnia, Sleep architecture, Z drugsAutores:Chávez-Castillo M., Contreras J., Hernández J.D., Martínez M.S., Nava M., Palmar J., Rivas M.G., Valmore BermúdezFuentes:scopusPotential role of bioactive lipids in rheumatoid arthritis
ReviewAbstract: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that involves a pathologicalPalabras claves:Autoimmune Disease, Bioactive lipids, Cardiovascular disease, inflammation, Resolving, Rheumatoid ArthritisAutores:Cano-Ponce C., Carrasquero R., Chávez-Castillo M., de Sanctis J.B., Diaz M.P., Gomez Y., González M.C., Peréz-Vicuña J.L., Ramírez P., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusSpecialized pro-resolving lipid mediators: The future of chronic pain therapy?
ReviewAbstract: Chronic pain (CP) is a severe clinical entity with devastating physical and emotional con-sequencesPalabras claves:Central nervous system sensitization, Chronic pain, Eicosanoids, inflammation, Long-term poten-tiation, Nociception, Omega 3 fatty acids, pain management, Polyunsaturated fatty acids, Specialized pro-resolving lipid mediatorsAutores:Chávez-Castillo M., de Sanctis J.B., Durán P., Garrido B., Manzano A., Ortega A., Rojas M., Rojas-Gómez D.M., Salazar-Vílchez J., Silva A., Torres L.C., Valmore BermúdezFuentes:scopus